Año: 2024
Journal Impact Factor (JIF): 7.30
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| GENETICS & HEREDITY | SCIE | 16/191 | Q1 | T1 | D1 |
| BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | 39/319 | Q1 | T1 | D2 |
| CELL BIOLOGY | SCIE | 39/204 | Q1 | T1 | D2 |
| ONCOLOGY | SCIE | 43/326 | Q1 | T1 | D2 |
Año: 2024
Journal Citation Indicator (JCI): 1,510
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| BIOCHEMISTRY & MOLECULAR BIOLOGY | 30/320 | Q1 | T1 | D1 | 90,78 |
| CELL BIOLOGY | 30/204 | Q1 | T1 | D2 | 85,54 |
| GENETICS & HEREDITY | 17/191 | Q1 | T1 | D1 | 91,36 |
| ONCOLOGY | 42/326 | Q1 | T1 | D2 | 87,27 |
Año:
2024
CiteScore:
15,400
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Genetics | 16/348 | Q1 | T1 | D1 |
| Molecular Biology | 34/410 | Q1 | T1 | D1 |
| Cancer Research | 25/233 | Q1 | T1 | D2 |
SJR año:
2024
Factor de Impacto:
2,489
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Genetics | 25/357 | Q1 | T1 | D1 |
| Cancer Research | 38/235 | Q1 | T1 | D2 |
| Molecular Biology | 47/424 | Q1 | T1 | D2 |
| Agencia | Código de Proyecto |
|---|---|
| University of Seville | - |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Olmedo-Pelayo, J | Universidad de Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); CIBERONC (Spain) |
| 2 | Granado-Calle, E | CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); University of Seville Department of Genetics (Spain) |
| 3 | Delgado-Bellido, D | CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); CIBERONC (Spain) |
| 4 | Lobo-Selma, L | CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); CIBERONC (Spain) |
| 5 | Jordan-Perez, C | CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); CIBERONC (Spain) |
| 6 | Monteiro-Amaral, AT | CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Universidade de Coimbra; CIBERONC (Spain) |
| 7 | Ehlers, AC | German Cancer Research Center (DKFZ); Hopp Childrens Canc Ctr KiTZ (Germany) |
| 8 | Ohmura, S | German Cancer Research Center (DKFZ); Hopp Childrens Canc Ctr KiTZ (Germany) |
| 9 | Garcia-Dominguez, DJ | Universidad de Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS) (Spain) |
| 10 | Mackintosh, C | Bristol Myers Squibbs Ctr Innovat & Translat Res E (Spain) |
| 11 | Carcaboso, AM | University of Barcelona; Inst Recerca St Joan de Deu (Spain) |
| 12 | Alonso, J | CIBERER; Instituto de Investigación de Enfermedades Raras (IIER) (Spain) |
| 13 | Machado, I | Instituto Valenciano de Oncologia; quironsalud Group (Spain) |
| 14 | Llombart-Bosch, A | University of Valencia (Spain) |
| 15 | Scotlandi, K | IRCCS Ist Ortoped Rizzoli (Italy) |
| 16 | Grünewald, TGP | Ruprecht Karls University Heidelberg; German Cancer Research Center (DKFZ); Hopp Childrens Canc Ctr KiTZ (Germany) |
| 17 | CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); University of Seville Department of Genetics (Spain) | |
| 18 | Universidad de Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); CIBERONC (Spain) |
